Logo Istituto Affiliato

IOR

An institute

affiliated to USI

Preclinical Development of Cancer Nanomedicines: State of the Art and Future Perspectives

Institute of Oncology Research

Data d'inizio: 24.03.2022 / 09:30

Data di fine: 25.03.2022 / 17:30

COST ACTION CA 17140 - Nano2Clinic
Cancer Nanomedicine - from the bench to the bedside

CLICK HERE TO DOWNLOAD THE PROGRAM

 

For more information: https://www.nano2clinic.eu

Contact person: anna.redaelli@ior.usi.ch ; +41 58 666 7010